Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
VA ›
VALIDIVE
Trademark search for:
VALIDIVE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-12-16 — Application filed
2012-03-22 — Sn assigned for sect 66a appl from ib
2012-03-23 — Application filed
2012-03-25 — Assigned to examiner
2012-03-27 — Application filed
2012-04-03 — Final disposition recorded
2012-04-04 — Office action issued
2012-04-06 — Office action issued
2012-04-06 — Office action issued
2012-04-27 — Office action issued
2012-05-07 — Assigned to examiner
2012-07-10 — Office action issued
2012-07-10 — Correspondence received in law office
2012-07-11 — Teas/email correspondence entered
2012-07-28 — Approved for pub - principal register
2012-08-10 — Assigned to lie
2012-08-10 — Law office publication review completed
2012-08-29 — Notification of possible opposition sent to ib
2012-08-29 — Notification of notice of publication e-mailed
2012-08-29 — Notice of start of opposition period created, to be sent to ib
2012-09-18 — Published for opposition
2012-09-18 — Official gazette publication confirmation e-mailed
2012-10-16 — Notification processed by ib
2012-12-04 — Registered-principal register
2013-03-04 — Final disposition recorded
2013-08-01 — Final disposition recorded
2013-08-01 — Final disposition recorded
2013-09-06 — Final disposition recorded
2014-10-30 — New representative at ib received
2015-06-26 — Change of name/address rec'd from ib
2017-12-04 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2018-11-09 — Teas section 71 received
2019-01-09 — Case assigned to post registration paralegal
2019-01-15 — Post registration action mailed - sec.71
2019-04-15 — Office action issued
2019-04-18 — Change of owner received from ib
2019-06-26 — Registered-sec.71 accepted
2019-06-26 — Notice of acceptance of sec. 71 - e-mailed
2021-12-04 — Courtesy reminder - sec. 71 (10-yr) e-mailed
2021-12-30 — International registration renewed
2023-06-16 — Cancelled section 71
2023-06-16 — Final status recorded
2024-02-16 — Total invalidation of reg ext protection created
2024-02-27 — Total invalidation of reg ext protection sent to ib
2024-02-27 — Invalidation processed
2024-03-17 — Total invalidation processed by the ib
Owner Information
Monopar Therapeutics Inc.
Wilmette , IL
ONXEO
FR
BIOALLIANCE PHARMA
PARIS FR
BIOALLIANCE PHARMA
PARIS FR
Correspondent
Richard M. LaBarge MARSHALL GERSTEIN & BORUN LLP 233 South Wacker Drive SUITE 6300 CHICAGO, IL 60606
Filing Details
Filing Date:
2011-12-16
Status Date:
2023-06-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.